Ocean Biomedical Stock Analysis
OCEA Stock | 0.71 0.01 1.43% |
Ocean Biomedical is undervalued with Real Value of 4.88 and Target Price of 17.45. The main objective of Ocean Biomedical stock analysis is to determine its intrinsic value, which is an estimate of what Ocean Biomedical is worth, separate from its market price. There are two main types of Ocean Biomedical's stock analysis: fundamental analysis and technical analysis.
The Ocean Biomedical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Ocean Biomedical's ongoing operational relationships across important fundamental and technical indicators.
Ocean |
Ocean Stock Analysis Notes
About 72.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 3.0. Ocean Biomedical had not issued any dividends in recent years. To find out more about Ocean Biomedical contact Elizabeth MBA at 401 444 7375 or learn more at https://www.oceanbiomedical.com.Ocean Biomedical Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Ocean Biomedical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Ocean Biomedical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Ocean Biomedical generated a negative expected return over the last 90 days | |
Ocean Biomedical has some characteristics of a very speculative penny stock | |
Ocean Biomedical has high historical volatility and very poor performance | |
Ocean Biomedical has a very high chance of going through financial distress in the upcoming years | |
Net Loss for the year was (114.47 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Ocean Biomedical generates negative cash flow from operations | |
About 72.0% of the company outstanding shares are owned by corporate insiders | |
Latest headline from seekingalpha.com: Ocean Biomedical receives notice from Nasdaq regarding late filing |
Ocean Largest EPS Surprises
Earnings surprises can significantly impact Ocean Biomedical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2023-08-14 | 2023-06-30 | -0.2 | -0.39 | -0.19 | 95 | ||
2023-02-23 | 2022-12-31 | -0.16 | 0.031 | 0.191 | 119 | ||
2024-04-15 | 2024-03-31 | -0.15 | -0.53 | -0.38 | 253 |
Ocean Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 25.64 M.Ocean Profitablity
Last Reported | Projected for Next Year | ||
Return On Capital Employed | (0.03) | (0.03) | |
Return On Equity | 0.01 | 0.01 |
Management Efficiency
Ocean Biomedical has return on total asset (ROA) of (6.8199) % which means that it has lost $6.8199 on every $100 spent on assets. This is way below average. Ocean Biomedical's management efficiency ratios could be used to measure how well Ocean Biomedical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Ocean Biomedical's Return On Tangible Assets are projected to decrease significantly based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0, whereas Return On Capital Employed is projected to grow to (0.03). At present, Ocean Biomedical's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 2.2 M, whereas Total Assets are forecasted to decline to about 5.2 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 2.57 | 2.70 | |
Tangible Book Value Per Share | 2.57 | 2.70 | |
Enterprise Value Over EBITDA | (358.39) | (376.31) | |
Price Book Value Ratio | 3.28 | 3.44 | |
Enterprise Value Multiple | (358.39) | (376.31) | |
Price Fair Value | 3.28 | 3.44 | |
Enterprise Value | 343.2 M | 209.1 M |
Ocean Biomedical benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Beta 1.529 | Return On Assets (6.82) |
Technical Drivers
As of the 3rd of December, Ocean Biomedical holds the Risk Adjusted Performance of (0.09), variance of 19.26, and Coefficient Of Variation of (810.07). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Ocean Biomedical, as well as the relationship between them.Ocean Biomedical Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Ocean Biomedical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Ocean Biomedical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Ocean Biomedical Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ocean Biomedical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ocean Biomedical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ocean Biomedical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ajjarapu Surendra K over six months ago Acquisition or disposition of Ocean Biomedical securities by Ajjarapu Surendra K | ||
Kathuria Chirinjeev over a year ago Acquisition or disposition of Ocean Biomedical securities by Kathuria Chirinjeev | ||
Ajjarapu Surendra K over a year ago Acquisition or disposition of Ocean Biomedical securities by Ajjarapu Surendra K | ||
Ajjarapu Surendra K over a year ago Acquisition or disposition of Ocean Biomedical securities by Ajjarapu Surendra K |
Ocean Biomedical Outstanding Bonds
Ocean Biomedical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Ocean Biomedical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Ocean bonds can be classified according to their maturity, which is the date when Ocean Biomedical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Ocean Biomedical Predictive Daily Indicators
Ocean Biomedical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Ocean Biomedical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Ocean Biomedical Forecast Models
Ocean Biomedical's time-series forecasting models are one of many Ocean Biomedical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ocean Biomedical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Ocean Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Ocean Biomedical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ocean shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Ocean Biomedical. By using and applying Ocean Stock analysis, traders can create a robust methodology for identifying Ocean entry and exit points for their positions.
Last Reported | Projected for Next Year |
Current Ocean Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ocean analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ocean analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
17.45 | Strong Sell | 0 | Odds |
Most Ocean analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Ocean stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Ocean Biomedical, talking to its executives and customers, or listening to Ocean conference calls.
Ocean Analyst Advice DetailsOcean Stock Analysis Indicators
Ocean Biomedical stock analysis indicators help investors evaluate how Ocean Biomedical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Ocean Biomedical shares will generate the highest return on investment. By understating and applying Ocean Biomedical stock analysis, traders can identify Ocean Biomedical position entry and exit signals to maximize returns.
Begin Period Cash Flow | 34 K | |
Total Stockholder Equity | -90.8 M | |
Cash And Short Term Investments | 4000.00 | |
Cash | 4000.00 | |
Accounts Payable | 933 K | |
Net Debt | 12.1 M | |
50 Day M A | 0.9434 | |
Total Current Liabilities | 30 M | |
Other Operating Expenses | 2.5 M | |
Non Current Assets Total | 3.4 M | |
Stock Based Compensation | 1.2 M |
Complementary Tools for Ocean Stock analysis
When running Ocean Biomedical's price analysis, check to measure Ocean Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocean Biomedical is operating at the current time. Most of Ocean Biomedical's value examination focuses on studying past and present price action to predict the probability of Ocean Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocean Biomedical's price. Additionally, you may evaluate how the addition of Ocean Biomedical to your portfolios can decrease your overall portfolio volatility.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |